Scarica l'app Stockscreener
4.49
3.94%
0.17
Precedente Chiudi:
$4.32
Aprire:
$4.33
Volume 24 ore:
79,467
Relative Volume:
0.78
Capitalizzazione di mercato:
$223.90M
Reddito:
$15.33M
Utile/perdita netta:
$-40.19M
Rapporto P/E:
-2.5625
EPS:
-1.7522
Flusso di cassa netto:
-
1 W Prestazione:
-3.02%
1M Prestazione:
+1.35%
6M Prestazione:
-18.51%
1 anno Prestazione:
+5.90%
Intervallo 1D:
$4.19
$4.49
Intervallo di 1 settimana:
$4.19
$4.85
Portata 52W:
$3.42
$5.88
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Nome
Trisalus Life Sciences Inc
Settore
Industria
Telefono
415 336 8917
Indirizzo
6272 WEST 91ST AVENUE, WESTMINSTER
Confronta TLSI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
4.49 | 215.43M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
132.37 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.63 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.65 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.05 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.29 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-13 | Iniziato | Lake Street | Buy |
| 2024-12-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-11-11 | Iniziato | ROTH MKM | Buy |
| 2024-10-25 | Iniziato | Northland Capital | Outperform |
| 2024-09-16 | Iniziato | Oppenheimer | Outperform |
| 2024-05-30 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Trisalus Life Sciences Inc Borsa (TLSI) Ultime notizie
Regression analysis insights on TriSalus Life Sciences Inc. Equity Warrant performanceJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com
Will TriSalus Life Sciences Inc. stock attract more institutional investorsWeekly Stock Summary & Accurate Buy Signal Alerts - newser.com
Will TriSalus Life Sciences Inc. stock gain from strong economyPortfolio Risk Summary & Fast Moving Trade Plans - newser.com
What high frequency data says about TriSalus Life Sciences Inc.2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
Will breakout in TriSalus Life Sciences Inc. Equity Warrant lead to full recoveryMarket Movement Recap & Technical Confirmation Alerts - newser.com
Tools to monitor TriSalus Life Sciences Inc. recovery probabilityJuly 2025 Closing Moves & High Accuracy Trade Alerts - newser.com
Statistical indicators supporting TriSalus Life Sciences Inc. Equity Warrant’s strengthJuly 2025 Outlook & Technical Pattern Based Buy Signals - newser.com
Will TriSalus Life Sciences Inc. Equity Warrant stock recover after recent dropJuly 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
Automated trading signals detected on TriSalus Life Sciences Inc. Equity WarrantMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
Is it time to cut losses on TriSalus Life Sciences Inc.July 2025 PostEarnings & Real-Time Volume Analysis - newser.com
Published on: 2025-10-10 09:12:22 - newser.com
Will TriSalus Life Sciences Inc. stock deliver strong dividend growthJuly 2025 Weekly Recap & Daily Profit Focused Stock Screening - newser.com
Sentiment analysis tools applied to TriSalus Life Sciences Inc.Quarterly Portfolio Report & Growth Focused Entry Reports - newser.com
TriSalus Life Sciences' (TLSI) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Published on: 2025-10-09 04:25:24 - newser.com
Volume spikes in TriSalus Life Sciences Inc. Equity Warrant stock – what they meanQuarterly Profit Review & AI Powered Market Entry Ideas - newser.com
Relative strength of TriSalus Life Sciences Inc. in sector analysisJobs Report & Short-Term Swing Trade Alerts - newser.com
Tick level data insight on TriSalus Life Sciences Inc. volatilityShare Buyback & Free Weekly Watchlist of Top Performers - newser.com
How TriSalus Life Sciences Inc. stock reacts to oil pricesJuly 2025 Outlook & Long-Term Safe Investment Ideas - newser.com
Quantitative breakdown of TriSalus Life Sciences Inc. recent moveMarket Weekly Review & Low Risk Growth Stock Ideas - newser.com
Will TriSalus Life Sciences Inc. outperform the marketWeekly Trend Report & Consistent Income Trade Ideas - newser.com
Using Bollinger Bands to evaluate TriSalus Life Sciences Inc. Equity Warrant2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
Is it too late to sell TriSalus Life Sciences Inc.July 2025 Update & Low Drawdown Trading Techniques - newser.com
How hedge fund analytics apply to TriSalus Life Sciences Inc. Equity Warrant stockJuly 2025 Fed Impact & Low Drawdown Investment Strategies - newser.com
How to build a custom watchlist for TriSalus Life Sciences Inc. Equity WarrantRecession Risk & Trade Opportunity Analysis - newser.com
Tools to monitor TriSalus Life Sciences Inc. Equity Warrant recovery probabilityTrade Analysis Summary & Safe Capital Allocation Plans - newser.com
What analysts say about TriSalus Life Sciences Inc stockHigh Beta Stocks & High Profit Market Tips - earlytimes.in
TriSalus Life Sciences director Sean Murphy resigns from board By Investing.com - Investing.com Canada
TriSalus Life Sciences director Sean Murphy resigns from board - Investing.com India
33,900 Shares in TriSalus Life Sciences, Inc. $TLSI Bought by Goldman Sachs Group Inc. - Defense World
Trisalus Life Sciences Inc Azioni (TLSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Trisalus Life Sciences Inc Azioni (TLSI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Devlin Jodi | Chief of Clinical Operations |
May 19 '25 |
Sale |
5.18 |
4,764 |
24,678 |
52,764 |
| Marshak Richard | Chief Commercial Officer |
May 19 '25 |
Sale |
5.18 |
6,597 |
34,172 |
69,101 |
| Stevens Jennifer | Chief Regulatory Officer |
May 19 '25 |
Sale |
5.18 |
8,704 |
45,087 |
77,640 |
| Young James Emmett | Chief Financial Officer |
Feb 05 '25 |
Buy |
5.65 |
6,000 |
33,900 |
30,000 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 30 '25 |
Buy |
5.28 |
5,010 |
26,453 |
444,259 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 29 '25 |
Buy |
5.03 |
5,030 |
25,301 |
439,249 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 27 '25 |
Buy |
5.42 |
4,826 |
26,157 |
429,503 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 28 '25 |
Buy |
5.12 |
4,716 |
24,146 |
434,219 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 27 '25 |
Buy |
5.31 |
15,000 |
79,650 |
182,732 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 28 '25 |
Buy |
5.17 |
15,000 |
77,550 |
197,732 |
0.86%
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):